Type 2 diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Daily half micrograms of calcitriol for 12 weeks. Intervention 2: Placebo for 12 weeks.
Treatment - Drugs
Placebo
Daily half micrograms of calcitriol for 12 weeks
Sponsors
Cellular Molecular Research Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patient's consent for participation in the study; Final diagnosis of Type 2 diabetes based on standard criteria; having no advanced nephrology and liver diseases as well as any other chronic diseases based on patient biography and clinical examination; having 0.7.5% = HBA1C = 7%. Exclusion criteria: Non-satisfaction of the patient for participation in the study; any chronic debilitive critical diseases based on patient biography and clinical examination; improper diabetes control HBA1C>7.5%; taking any calcium and vitamin D supplement during the last six months.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measure of glycosylated hemoglobin (HbA1c). Timepoint: 3 months. Method of measurement: Laboratory.;Fasting glucose levels. Timepoint: 3 months. Method of measurement: Laboratory.;Glucose levels 2 hours after a meal. Timepoint: 3 months. Method of measurement: Laboratory.;Total cholesterol and triglyceride levels and LDL-C and HDL-C. Timepoint: 3 months. Method of measurement: Laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vitamin D level. Timepoint: 3 months. Method of measurement: Laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Kamran Roudini
Shahr-e-Kord University of Medical Sciences
Outcome results
None listed